Identification of a Gene Prognostic Signature for Oral Squamous Cell Carcinoma by RNA Sequencing and Bioinformatics

Table 3

The clinical parameters of HNSCC patients.

Subgroup	Frequency	Percentage	Valid percentage
Age
<60	220	44.1	44.1
≥60	279	55.9	55.9
Gender
Male	366	73.3	73.3
Female	133	26.7	26.7
Stage
I+II	105	21.0	21.0
III+IV	394	79.0	79.0
T stage
Tis, T1, T2	176	35.3	36.1
T3	132	26.5	27.0
T4	180	36.1	36.9
N stage
N0	240	48.1	50.0
N1+N2	240	48.1	50.0
M stage
M0	474	95.0	99.0
M1	5	1.0	1.0
Neoplasm status
Tumor free	314	62.9	69.6
With tumor	137	27.5	30.4
Vital status
Alive	282	56.5	56.5
Dead	217	43.5	43.5
Risk level
High	249	49.9	49.9
Low	250	50.1	50.1